We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

2 hedge funds and large institutions have $3M invested in Amphastar Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$1.96M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$982K

Top Sellers

No sellers this quarter

AMPH Hedge Fund Activity: Q2 2014 in Review

2 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q2 2014, worth a combined $3M.

Buyers outnumbered sellers: 2 funds opened new AMPH positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $1.96M.

  • 2 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $3M of Amphastar Pharmaceuticals stock for Q2 2014.
  • 2 funds opened new Amphastar Pharmaceuticals positions in Q2 2014 and 0 closed out, a net change of +2 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q2 2014 was Kennedy Capital Management, an estimated $1.96M added.

Based on aggregated 13F filings for Q2 2014.